Search Within

Arnab Ghosh

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (7)
Groups
  1. Department of Medicine (21)
  2. GSK Faculty (21)
  3. Hematologic Malignancies, Division of (21)
  4. Molecular Pharmacology and Chemistry Program Faculty (21)
  5. Sloan Kettering Institute Faculty (21)
  6. Weinberg Fellows (21)

More Groups

People
  1. Marcel Van Den Brink (17)
  2. Amanda Holland (15)
  3. Robert Jenq (15)
  4. Michel Sadelain (14)
  5. Odette Smith (12)
  6. Alan Hanash (11)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2013 (3)
  6. 2012 (3)

More Years

Publications
  1. Blood (7)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Cancer Research (3)
  4. Bone Marrow Transplantation (1)
  5. Immunity (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (3)
  4. Nature Publishing Group (3)
  5. American Society for Clinical Investigation (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours
    Journal Article

    Zappasodi, R.; Serganova, I.; Cohen, I. J.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Watson, M. J.; Leftin, A.; Maniyar, R.; Verma, S.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade drives loss of regulatory T cell functional stability in glycolysis defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Leftin, A.; Maniyar, R.; Verma, S.; Lubin, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
    Journal Article

    Ghosh, A.; Smith, M.; James, S. E.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Perna, F.; Kreines, F. M.; Levy, E. R.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease
    Meeting Abstract

    Smith, M.; Ghosh, A.; James, S.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Schietinger, A.; Sadelain, M. W.; van den Brink, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Donor CD19-targeted T cells exert potent graft versus lymphoma activity without GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M.; Young, L.; Jenq, R.; Sadelain, M.; Van Den Brink, M.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD
    Journal Article

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N. L.; Rao, U. K.; Young, L. F.; West, M. L.; Singer, N. V.; Lee, H.; Na, I. K.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
    Journal Article

    Ghosh, A.; Dogan, Y.; Moroz, M.; Holland, A. M.; Yim, N. L.; Rao, U. K.; Young, L. F.; Tannenbaum, D.; Masih, D.; Velardi, E.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M. L.; Young, L. F.; Kloss, C.; Gunset, G.; Smith, O. M.; West, M. L.; Singer, N. V.; Holland, A. M.; Jenq, R. R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease
    Journal Article

    Hanash, A.; Dudakov, J.; Hua, G.; O'connor, M.; Young, L.; Singer, N.; West, M.; Jenq, R.; Holland, A.; Kappel, L.; more...
    Immunity (2012)

    Fulltext@MSK | Save